[go: up one dir, main page]

AR023480A1 - METHODS FOR SOLID PHASE COMBINATORY SYNTHESIS OF INTEGRINE INHIBITORS - Google Patents

METHODS FOR SOLID PHASE COMBINATORY SYNTHESIS OF INTEGRINE INHIBITORS

Info

Publication number
AR023480A1
AR023480A1 ARP000101713A ARP000101713A AR023480A1 AR 023480 A1 AR023480 A1 AR 023480A1 AR P000101713 A ARP000101713 A AR P000101713A AR P000101713 A ARP000101713 A AR P000101713A AR 023480 A1 AR023480 A1 AR 023480A1
Authority
AR
Argentina
Prior art keywords
integrine
inhibitors
methods
solid phase
rheumatoid arthritis
Prior art date
Application number
ARP000101713A
Other languages
Spanish (es)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of AR023480A1 publication Critical patent/AR023480A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/08—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Los compuestos de la formula (1) son utiles en el tratamiento de diversos trastornos incluyendo, aunque sin limitarse a, cáncer (metástasis tumoral,tumorgénesis/crecimiento tumoral), angiogénesis (como en cáncer, retinopatía diabética, artritis reumatoide), restenosis (luego de angioplastía con balono implante de stent), inflamacion (como en artritis reumatoide, psoriasis), enfermedades oseas (osteopenia inducida por metástasis osea, inmovilizacion ytratamiento con glucocorticoides, enfermedad piriodontal, hiperparatiroidismo y artritis reumatoide), y como agentes antivirales. También se provee un métodonovedoso para preparar compuestos de formula (1).The compounds of the formula (1) are useful in the treatment of various disorders including, but not limited to, cancer (tumor metastasis, tumor growth / tumor growth), angiogenesis (as in cancer, diabetic retinopathy, rheumatoid arthritis), restenosis (then of angioplasty with stent implant balon), inflammation (as in rheumatoid arthritis, psoriasis), bone diseases (osteopenia induced by bone metastasis, immobilization and treatment with glucocorticoids, pyriodontal disease, hyperparathyroidism and rheumatoid arthritis), and as antiviral agents. A method for preparing compounds of formula (1) is also provided.

ARP000101713A 1999-04-14 2000-04-13 METHODS FOR SOLID PHASE COMBINATORY SYNTHESIS OF INTEGRINE INHIBITORS AR023480A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29147099A 1999-04-14 1999-04-14

Publications (1)

Publication Number Publication Date
AR023480A1 true AR023480A1 (en) 2002-09-04

Family

ID=23120428

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101713A AR023480A1 (en) 1999-04-14 2000-04-13 METHODS FOR SOLID PHASE COMBINATORY SYNTHESIS OF INTEGRINE INHIBITORS

Country Status (3)

Country Link
AR (1) AR023480A1 (en)
AU (1) AU4242100A (en)
WO (1) WO2000061545A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8811401A (en) 2000-09-25 2002-04-02 Toray Industries Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
US6818659B2 (en) 2001-11-06 2004-11-16 Bristol-Myers Squibb Pharma, Inc. (2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides
DE102006033321A1 (en) * 2006-07-17 2008-01-24 Westfälische Wilhelms-Universität Münster Medical use of N-phenylpropenoyl amino acid derivatives and related compounds
SI3050878T1 (en) 2013-09-24 2022-01-31 Fujifilm Corporation Novel nitrogen-containing compound or salt thereof, or metal complex thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681820A (en) * 1995-05-16 1997-10-28 G. D. Searle & Co. Guanidinoalkyl glycine β-amino acids useful for inhibiting tumor metastasis
ATE203234T1 (en) * 1995-08-30 2001-08-15 Searle & Co META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINOBENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS
WO1999052879A1 (en) * 1998-04-14 1999-10-21 American Home Products Corporation Acylresorcinol derivatives as selective vitronectin receptor inhibitors

Also Published As

Publication number Publication date
WO2000061545A1 (en) 2000-10-19
AU4242100A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
DK1187592T3 (en) Alpha v integrin receptor antagonists
PE28797A1 (en) DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO
UY27224A1 (en) INHIBITORS OF RHO-QUINASA
UY24880A1 (en) ARILSULFONIL HYDROXAMIC ACID DERIVATIVES
BR9808010B1 (en) 2-ALKYL-19-NOR-VITAMIN D COMPOUNDS AND PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME
DE60318177D1 (en) RHO-KINASE INHIBITORS
UY27225A1 (en) INHIBITORS OF RHO-QUINASA
ATE298338T1 (en) INTEGRIN RECEPTOR ANTAGONISTS
PA8456801A1 (en) DERIVATIVES OF ARILOXIARILSULFONILAMINO HIDROXAMICOS ACIDS
AR010873A1 (en) VITRONECTIN RECEPTOR ANTAGONIST COMPOUNDS, INTERMEDIARIES, METHODS OF THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS, USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF MEDICINES.
DE69720771T2 (en) INTEGRIN ANTAGONIST
ATE294163T1 (en) INTEGRIN RECEPTOR ANTAGONISTS
BR0112453A (en) Methods of treating metabolic bone disease, psoriasis, leukemia, colon, sinus or prostate cancer and increasing bone strength and use of a compass
SV2002000357A (en) MALONAMIC ACIDS AND DERIVATIVES OF THE SAME AS THYROID RECEIVER LIGANDS REF PC10748AMAG / BB
ATE225167T1 (en) USE OF FATTY ACID SYNTHESIS INHIBITORS FOR THE TREATMENT OF CANCER
ATE353219T1 (en) ALPHA V INTEGRIN RECEPTOR ANTAGONISTS
DK1594885T3 (en) Drug for growth inhibition of tumors
AR023480A1 (en) METHODS FOR SOLID PHASE COMBINATORY SYNTHESIS OF INTEGRINE INHIBITORS
Özgeriş et al. Synthesis and anticancer activity of novel ureas and sulfamides incorporating 1-aminotetralins
UY26951A1 (en) DERIVATIVES OF OWN ACID
WO2002022616A3 (en) Alpha v integrin receptor antagonists
AR042065A1 (en) A METHOD FOR PREPARING INDANO-1,3-DICARBOXYL ACID
ATE320258T1 (en) DIBENZOXAZEPINE ALPHA V INTEGRIN RECEPTOR ANTAGONIST
ECSP003775A (en) INTEGRIN ALFA V RECEIVER ANTAGONISTS
HN2002000068A (en) INHIBITORS OF THE RHO - QUINASA.